World Bank debars two firms under India Reproductive and Child Health Projects
The World Bank has declared two India-based firms, Nestor Pharmaceuticals Ltd. (Nestor) and Pure Pharma Ltd. (Pure Pharma), ineligible to be awarded Bank-financed contracts. Both firms were found to have engaged in collusive practices in connection with the Bank-financed Reproductive and Child Health Project (RCH I) in India. Nestor has been debarred for a period of three years, while Pure Pharma is debarred for one year.
